Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell lineABAL, Miguel; BRAS-GONCALVES, Rui; JUDDE, Jean-Gabriel et al.Oncogene (Basingstoke). 2004, Vol 23, Num 9, pp 1737-1744, issn 0950-9232, 8 p.Article

The histone-deacetylase inhibitor MS-275 and the CDK-inhibitor CYC-202 promote anti-tumor effects in hepatoma cell linesGAHR, Susanne; PETER, Gisela; WISSNIOWSKI, Thadäus Till et al.Oncology reports. 2008, Vol 20, Num 5, pp 1249-1256, issn 1021-335X, 8 p.Article